Mpm Oncology Impact Management Gp Llc - Net Worth and Insider Trading
Mpm Oncology Impact Management Gp Llc Net Worth
The estimated net worth of Mpm Oncology Impact Management Gp Llc is at least $506,390 dollars as of 2024-04-26. Mpm Oncology Impact Management Gp Llc is the 10% Owner of Sunesis Pharmaceuticals Inc and owns about 95,186 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $506,390. Details can be seen in Mpm Oncology Impact Management Gp Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mpm Oncology Impact Management Gp Llc has not made any transactions after 2017-11-06 and currently still holds the listed stock(s).
Transaction Summary of Mpm Oncology Impact Management Gp Llc
Mpm Oncology Impact Management Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Oncology Impact Management Gp Llc owns 10 companies in total, including Oncorus Inc (ONCR) , ITeos Therapeutics Inc (ITOS) , and TCR2 Therapeutics Inc (TCRR) among others .
Insider Ownership Summary of Mpm Oncology Impact Management Gp Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-01 | 10 percent owner |
| ITOS | ITeos Therapeutics Inc | 2020-07-23 | other: X* |
| TCRR | TCR2 Therapeutics Inc | 2019-02-13 | 10 percent owner |
| HARP | Harpoon Therapeutics Inc | 2019-02-07 | 10 percent owner |
| SNSS | Sunesis Pharmaceuticals Inc | 2017-11-06 | 10 percent owner |
| SBPH | Spring Bank Pharmaceuticals Inc | 2017-03-25 | 10 percent owner |
| VIRX | Viracta Therapeutics Inc | 2017-10-27 | 10 percent owner |
| FSTX | F-star Therapeutics Inc | 2017-03-25 | 10 percent owner |
| HOWL | Werewolf Therapeutics Inc | 2021-04-29 | 10 percent owner |
| CGEM | Cullinan Therapeutics Inc | 2021-01-07 | 10 percent owner |
Mpm Oncology Impact Management Gp Llc Latest Holdings Summary
Mpm Oncology Impact Management Gp Llc currently owns a total of 1 stock. Mpm Oncology Impact Management Gp Llc owns 95,186 shares of Sunesis Pharmaceuticals Inc (SNSS) as of November 6, 2017, with a value of $506,390.
Latest Holdings of Mpm Oncology Impact Management Gp Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2017-11-06 | 95,186 | 5.32 | 506,390 |
Holding Weightings of Mpm Oncology Impact Management Gp Llc
Mpm Oncology Impact Management Gp Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Mpm Oncology Impact Management Gp Llc has made a total of 0 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 2,329 shares on November 6, 2017, which cost Mpm Oncology Impact Management Gp Llc around $225,755.
Insider Trading History of Mpm Oncology Impact Management Gp Llc
- 1
Mpm Oncology Impact Management Gp Llc Trading Performance
GuruFocus tracks the stock performance after each of Mpm Oncology Impact Management Gp Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Oncology Impact Management Gp Llc is 105.15%. GuruFocus also compares Mpm Oncology Impact Management Gp Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Oncology Impact Management Gp Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mpm Oncology Impact Management Gp Llc's insider trading performs compared to the benchmark.
Performance of Mpm Oncology Impact Management Gp Llc
Average Return
-53.61%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.65 | 105.15 | -4.81 | -53.61 | -59.9 | -66.1 |
| Relative Return to S&P 500(%) | -23.12 | 101.14 | -7.6 | -59.95 | -68.87 | -76.73 |
Mpm Oncology Impact Management Gp Llc Ownership Network
Ownership Network List of Mpm Oncology Impact Management Gp Llc
Ownership Network Relation of Mpm Oncology Impact Management Gp Llc
Mpm Oncology Impact Management Gp Llc Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Mpm Oncology Impact Management Gp Llc is the 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
Over the past 18 months, Mpm Oncology Impact Management Gp Llc made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
Mpm Oncology Impact Management Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Oncology Impact Management Gp Llc. You might contact Mpm Oncology Impact Management Gp Llc via mailing address: 450 Kendall Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
